Back
Hot Pursuit
AstraZeneca Pharma India Limited receives a stay on NPPA’s demand notice regarding overcharging for Betaloc-50 tablets
25-Aug-2026, 10:01
AstraZeneca Pharma India Limited announced that the Hon'ble High Court of Delhi has stayed the operation of a demand notice dated July 27, 2026, issued by the National Pharmaceutical Pricing Authority (NPPA) alleging overcharging for Betaloc-50 tablets, until a hearing on February 10, 2027. The NPPA alleges that AstraZeneca Pharma India Ltd. sold the medication at a price exceeding the ceiling set under the Drugs (Prices Control) Order, 2013, between June and July 2016, resulting in a demand for recovery of overcharged amounts plus interest; as part of the stay, the company is required to deposit 15% of the amount mentioned in the Demand Notice with the Registrar General of the Delhi High Court.
AstraZeneca Pharma India Limited announced that the Hon'ble High Court of Delhi has stayed the operation of a demand notice dated July 27, 2026, issued by the National Pharmaceutical Pricing Authority (NPPA) alleging overcharging for Betaloc-50 tablets, until a hearing on February 10, 2027. The NPPA alleges that AstraZeneca Pharma India Ltd. sold the medication at a price exceeding the ceiling set under the Drugs (Prices Control) Order, 2013, between June and July 2016, resulting in a demand for recovery of overcharged amounts plus interest; as part of the stay, the company is required to deposit 15% of the amount mentioned in the Demand Notice with the Registrar General of the Delhi High Court.